HEADER BIOSYNTHETIC PROTEIN 13-DEC-17 6BVU TITLE SFTI-HFRW-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN INHIBITOR 1 HFRW-1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HELIANTHUS ANNUUS; SOURCE 4 ORGANISM_COMMON: COMMON SUNFLOWER; SOURCE 5 ORGANISM_TAXID: 4232 KEYWDS BIOSYNTHETIC PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.I.SCHROEDER REVDAT 5 14-JUN-23 6BVU 1 LINK REVDAT 4 08-JAN-20 6BVU 1 REMARK REVDAT 3 03-JUL-19 6BVU 1 JRNL REMARK LINK REVDAT 2 20-FEB-19 6BVU 1 REMARK REVDAT 1 19-DEC-18 6BVU 0 JRNL AUTH T.DUREK,P.M.CROMM,A.M.WHITE,C.I.SCHROEDER,Q.KAAS,J.WEIDMANN, JRNL AUTH 2 A.AHMAD FUAAD,O.CHENEVAL,P.J.HARVEY,N.L.DALY,Y.ZHOU, JRNL AUTH 3 A.DELLSEN,T.OSTERLUND,N.LARSSON,L.KNERR,U.BAUER,H.KESSLER, JRNL AUTH 4 M.CAI,V.J.HRUBY,A.T.PLOWRIGHT,D.J.CRAIK JRNL TITL DEVELOPMENT OF NOVEL MELANOCORTIN RECEPTOR AGONISTS BASED ON JRNL TITL 2 THE CYCLIC PEPTIDE FRAMEWORK OF SUNFLOWER TRYPSIN JRNL TITL 3 INHIBITOR-1. JRNL REF J.MED.CHEM. V. 61 3674 2018 JRNL REFN ISSN 0022-2623 JRNL PMID 29605997 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00170 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 3.97 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BVU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1000231692. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 PA REMARK 210 SAMPLE CONTENTS : 1 MM AZ2, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-13C HSQC; 2D 1H-15N HSQC; REMARK 210 2D 1H-1H COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR, TOPSPIN, CYANA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 10 59.63 -105.87 REMARK 500 1 TRP A 13 -74.53 -104.01 REMARK 500 2 ALA A 3 49.02 -103.68 REMARK 500 2 ARG A 12 34.88 -95.78 REMARK 500 3 ALA A 3 43.09 -107.44 REMARK 500 3 SER A 4 -173.75 -68.32 REMARK 500 3 HIS A 10 40.28 -109.99 REMARK 500 3 ARG A 12 30.69 -97.33 REMARK 500 3 TRP A 13 -69.14 -108.47 REMARK 500 4 HIS A 10 52.10 -116.40 REMARK 500 4 ARG A 12 49.95 -89.31 REMARK 500 4 TRP A 13 -58.53 -127.68 REMARK 500 5 ALA A 3 43.47 -108.00 REMARK 500 5 HIS A 10 52.50 -103.99 REMARK 500 5 TRP A 13 -72.99 -102.06 REMARK 500 6 HIS A 10 51.30 -103.59 REMARK 500 6 TRP A 13 -73.85 -131.41 REMARK 500 7 HIS A 10 47.84 -100.38 REMARK 500 7 TRP A 13 -68.46 -105.87 REMARK 500 8 ALA A 3 48.56 -90.65 REMARK 500 9 ALA A 3 55.48 -96.02 REMARK 500 9 TRP A 13 -64.69 -108.31 REMARK 500 10 ARG A 12 41.20 -93.92 REMARK 500 10 TRP A 13 -71.92 -120.60 REMARK 500 11 ALA A 3 56.86 -95.42 REMARK 500 12 ALA A 3 39.26 -98.76 REMARK 500 12 SER A 4 -173.32 -64.77 REMARK 500 12 HIS A 10 41.41 -104.12 REMARK 500 13 ALA A 3 44.54 -92.40 REMARK 500 13 TRP A 13 -64.87 -101.99 REMARK 500 14 ARG A 12 47.41 -91.60 REMARK 500 14 TRP A 13 -56.61 -129.07 REMARK 500 15 ALA A 3 49.20 -103.68 REMARK 500 15 PRO A 7 -177.19 -69.72 REMARK 500 15 ARG A 12 45.07 -92.06 REMARK 500 15 TRP A 13 -61.75 -124.74 REMARK 500 17 ALA A 3 51.17 -110.90 REMARK 500 17 TRP A 13 -67.19 -103.06 REMARK 500 18 ALA A 3 38.34 -94.48 REMARK 500 18 TRP A 13 -60.80 -107.23 REMARK 500 19 ALA A 3 48.06 -89.97 REMARK 500 19 SER A 4 -172.76 -66.75 REMARK 500 19 ARG A 12 44.05 -92.67 REMARK 500 19 TRP A 13 -66.14 -128.38 REMARK 500 20 ALA A 3 59.70 -110.70 REMARK 500 20 HIS A 10 48.25 -99.48 REMARK 500 20 ARG A 12 45.75 -108.94 REMARK 500 20 TRP A 13 -68.44 -123.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30380 RELATED DB: BMRB REMARK 900 SFTI-HFRW-1 DBREF 6BVU A 1 14 PDB 6BVU 6BVU 1 14 SEQRES 1 A 14 CYS THR ALA SER ILE PRO PRO ILE CYS HIS DPN ARG TRP SEQRES 2 A 14 ARG HET DPN A 11 20 HETNAM DPN D-PHENYLALANINE FORMUL 1 DPN C9 H11 N O2 SSBOND 1 CYS A 1 CYS A 9 1555 1555 1.99 LINK N CYS A 1 C ARG A 14 1555 1555 1.33 LINK C HIS A 10 N DPN A 11 1555 1555 1.33 LINK C DPN A 11 N ARG A 12 1555 1555 1.33 CISPEP 1 ILE A 5 PRO A 6 1 -0.25 CISPEP 2 ILE A 5 PRO A 6 2 -0.13 CISPEP 3 ILE A 5 PRO A 6 3 -0.14 CISPEP 4 ILE A 5 PRO A 6 4 -0.03 CISPEP 5 ILE A 5 PRO A 6 5 -0.04 CISPEP 6 ILE A 5 PRO A 6 6 -0.21 CISPEP 7 ILE A 5 PRO A 6 7 -0.02 CISPEP 8 ILE A 5 PRO A 6 8 -0.20 CISPEP 9 ILE A 5 PRO A 6 9 -0.15 CISPEP 10 ILE A 5 PRO A 6 10 -0.03 CISPEP 11 ILE A 5 PRO A 6 11 -0.03 CISPEP 12 ILE A 5 PRO A 6 12 -0.12 CISPEP 13 ILE A 5 PRO A 6 13 -0.14 CISPEP 14 ILE A 5 PRO A 6 14 -0.12 CISPEP 15 ILE A 5 PRO A 6 15 -0.18 CISPEP 16 ILE A 5 PRO A 6 16 0.02 CISPEP 17 ILE A 5 PRO A 6 17 -0.09 CISPEP 18 ILE A 5 PRO A 6 18 -0.19 CISPEP 19 ILE A 5 PRO A 6 19 -0.19 CISPEP 20 ILE A 5 PRO A 6 20 -0.21 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1